跳到主要內容

DeLuca Teresa 的 Form 4/A 修正申報

修正

Surgery Partners, Inc.(SGRY),2026/8/20 申報

申報編號
0001638833-26-000081
申報時間
2026/8/20 18:10 ET
交易日
2026/8/18
申報延遲
2 天
10b5-1 計畫
沒有勾選
原始申報日
2026/8/19

這份申報列了 1 筆非衍生性交易。公開市場買進合計 $16.1 萬。交易後 2 天申報。

這份修正申報取代了 0001638833-26-000079(2026/8/19 申報)。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
DeLuca TeresaCIK 0001685627董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/8/18Common StockP買進取得+11,250$14.33F1+$161,212.568,093直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F2

This Form 4/A amends the Form 4 originally filed on August 19, 2026 to correct the number of shares of the Issuer's common stock purchased by the Reporting Person and the purchase price per share reported in Table I. The original Form 4 inadvertently reported the purchase of 10,000 shares at a price of $14.35 per share. The Reporting Person actually purchased 11,250 shares at a price of $14.33 per share. The amount of securities beneficially owned following the transaction has been corrected accordingly. Except as set forth herein, the original Form 4 remains unchanged.

看 SEC EDGAR 上的完整原文 (在新分頁開啟)